Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort.
Ragnhild HellesnesTor-Åge MyklebustSophie D FossåRoy M BremnesÁsa KarlsdottirØivind KvammenTorgrim TandstadTom WilsgaardHelene F S NegaardHege Sagstuen HaugnesPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
TC treatment with PBCT or RT is associated with a significant excess risk of non-TC mortality, and increased risks emerged after more than two cisplatin-based chemotherapy cycles after > 10 years of follow-up.